Albargawi et al. (2016) [16] suggested that creating a proper health locus of control in addition to self-efficacy could support adherence to oral drugs and insulin-based treatment, based on their sample of 30 Saudi T2DM patients. This evidence concerns the gene INS and type 2 diabetes mellitus.